FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387208043> ?p ?o ?g. }

• W4387208043 endingPage "e18" @default.
• W4387208043 startingPage "e17" @default.
• W4387208043 abstract "Stereotactic body radiation therapy (SBRT) is an effective alternative to surgery in the treatment of early-stage non-small cell lung cancer (NSCLC). However, disease recurrence occurs in approximately 20-30% of patients. Hypoxia is a well-known factor promoting solid tumor progression, radiation resistance, and immune evasion. In this study, we utilize a previously published hypoxia gene expression signature (Buffa) and measure its association with clinical outcomes in patients with NSCLC treated with SBRT.Our study focused on patients with localized, node-negative NSCLC treated with SBRT, and we identified 92 patients treated at our institution between 2008 and 2018 with available gene expression data. Total RNA from formalin-fixed paraffin-embedded archival biopsy specimens (pre-therapy) was isolated and mRNA expression was analyzed using an assay for human samples. For each gene in the Buffa signature, the top 50% of mRNA abundance values were given a score of +1, and the bottom 50% were given a score of -1 to generate a tumor hypoxia score. High scores suggest a hypoxic tumor and low scores imply normoxia. Kaplan-Meier curves were used to assess overall survival, disease-free survival, local recurrence, regional nodal recurrence, and distant recurrence. Cox proportional hazards were performed to account for confounding due to age, T stage, ECOG performance status, biologically effective dose, patient sex, and histology (squamous vs non-squamous).The patient's gene expression data were dichotomized based on their median hypoxia score (Table 1). Median follow-up was 23.9 months (95% CI 20.6 - 26.6). A high hypoxia score was associated with squamous histology (p = 0.003). On univariate analysis, a high hypoxia score was significantly associated with local recurrence (hazard ratio [HR] = 5.63; 95% CI 1.03 - 30.78; p = 0.046) and distant recurrence (HR = 1.85; 95% CI 1.14 - 3.02; p = 0.013). There was no significant difference in overall survival (HR = 1.93; 95% CI 0.98 - 3.82; p = 0.058), disease-free survival (HR = 2.13; 95% CI 0.93 - 4.89; p = 0.074), or regional nodal recurrence (HR = 1.45; 95% CI 0.41 - 5.14; p = 0.57). On multivariate analysis, a high hypoxia score was associated with worse overall survival (HR = 2.73; 95% CI 1.23 - 6.07; p = 0.014), local recurrence (HR = 12.85; 95% CI 1.08 - 152.49; p = 0.043) and distant recurrence (HR = 1.91; 95% CI 1.13 - 3.22; p = 0.016).Our findings demonstrate that a hypoxia gene signature is significantly associated with worse survival and increased local and distant recurrence after SBRT for localized NSCLC. This hypoxia signature may be useful in prognostication, selecting patients for surgery versus radiation, or selecting patients for treatment intensification with radiation or other systemic agents, and should be prospectively validated." @default.
• W4387208043 created "2023-09-30" @default.
• W4387208043 creator A5040079785 @default.
• W4387208043 creator A5040386391 @default.
• W4387208043 creator A5044479770 @default.
• W4387208043 creator A5051548428 @default.
• W4387208043 creator A5056692526 @default.
• W4387208043 creator A5061801009 @default.
• W4387208043 creator A5075965119 @default.
• W4387208043 date "2023-10-01" @default.
• W4387208043 modified "2023-10-17" @default.
• W4387208043 title "Prognostic Value of Hypoxia Gene Expression Signature in Early-Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy" @default.
• W4387208043 doi "https://doi.org/10.1016/j.ijrobp.2023.06.685" @default.
• W4387208043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37784778" @default.
• W4387208043 hasPublicationYear "2023" @default.
• W4387208043 type Work @default.
• W4387208043 citedByCount "0" @default.
• W4387208043 crossrefType "journal-article" @default.
• W4387208043 hasAuthorship W4387208043A5040079785 @default.
• W4387208043 hasAuthorship W4387208043A5040386391 @default.
• W4387208043 hasAuthorship W4387208043A5044479770 @default.
• W4387208043 hasAuthorship W4387208043A5051548428 @default.
• W4387208043 hasAuthorship W4387208043A5056692526 @default.
• W4387208043 hasAuthorship W4387208043A5061801009 @default.
• W4387208043 hasAuthorship W4387208043A5075965119 @default.
• W4387208043 hasConcept C104317684 @default.
• W4387208043 hasConcept C10515644 @default.
• W4387208043 hasConcept C126322002 @default.
• W4387208043 hasConcept C142724271 @default.
• W4387208043 hasConcept C143998085 @default.
• W4387208043 hasConcept C146357865 @default.
• W4387208043 hasConcept C150194340 @default.
• W4387208043 hasConcept C151730666 @default.
• W4387208043 hasConcept C178790620 @default.
• W4387208043 hasConcept C185592680 @default.
• W4387208043 hasConcept C2775934546 @default.
• W4387208043 hasConcept C2776256026 @default.
• W4387208043 hasConcept C2779733811 @default.
• W4387208043 hasConcept C50382708 @default.
• W4387208043 hasConcept C509974204 @default.
• W4387208043 hasConcept C540031477 @default.
• W4387208043 hasConcept C55493867 @default.
• W4387208043 hasConcept C71924100 @default.
• W4387208043 hasConcept C77350462 @default.
• W4387208043 hasConcept C7836513 @default.
• W4387208043 hasConcept C86803240 @default.
• W4387208043 hasConceptScore W4387208043C104317684 @default.
• W4387208043 hasConceptScore W4387208043C10515644 @default.
• W4387208043 hasConceptScore W4387208043C126322002 @default.
• W4387208043 hasConceptScore W4387208043C142724271 @default.
• W4387208043 hasConceptScore W4387208043C143998085 @default.
• W4387208043 hasConceptScore W4387208043C146357865 @default.
• W4387208043 hasConceptScore W4387208043C150194340 @default.
• W4387208043 hasConceptScore W4387208043C151730666 @default.
• W4387208043 hasConceptScore W4387208043C178790620 @default.
• W4387208043 hasConceptScore W4387208043C185592680 @default.
• W4387208043 hasConceptScore W4387208043C2775934546 @default.
• W4387208043 hasConceptScore W4387208043C2776256026 @default.
• W4387208043 hasConceptScore W4387208043C2779733811 @default.
• W4387208043 hasConceptScore W4387208043C50382708 @default.
• W4387208043 hasConceptScore W4387208043C509974204 @default.
• W4387208043 hasConceptScore W4387208043C540031477 @default.
• W4387208043 hasConceptScore W4387208043C55493867 @default.
• W4387208043 hasConceptScore W4387208043C71924100 @default.
• W4387208043 hasConceptScore W4387208043C77350462 @default.
• W4387208043 hasConceptScore W4387208043C7836513 @default.
• W4387208043 hasConceptScore W4387208043C86803240 @default.
• W4387208043 hasIssue "2" @default.
• W4387208043 hasLocation W43872080431 @default.
• W4387208043 hasLocation W43872080432 @default.
• W4387208043 hasOpenAccess W4387208043 @default.
• W4387208043 hasPrimaryLocation W43872080431 @default.
• W4387208043 hasRelatedWork W2407189953 @default.
• W4387208043 hasRelatedWork W3036457781 @default.
• W4387208043 hasRelatedWork W3080875544 @default.
• W4387208043 hasRelatedWork W3102307445 @default.
• W4387208043 hasRelatedWork W3156052029 @default.
• W4387208043 hasRelatedWork W3168077393 @default.
• W4387208043 hasRelatedWork W3175948527 @default.
• W4387208043 hasRelatedWork W3200659145 @default.
• W4387208043 hasRelatedWork W4312123460 @default.
• W4387208043 hasRelatedWork W4366825146 @default.
• W4387208043 hasVolume "117" @default.
• W4387208043 isParatext "false" @default.
• W4387208043 isRetracted "false" @default.
• W4387208043 workType "article" @default.